IP Library › Granted Patent US 12,725,751
Granted Patent B2
US 12,725,751 · App. 18/498,767 · Granted Sep 1, 2026

Implantable medical device selective encapsulation

Inventors: Katherine Provo (Plymouth, MN); James Michael English (Cahir, IE); Shane McGrath (Thurles, IE); Joseph Thomas Delaney, Jr. (Minneapolis, MN)
H01J11/20H01J9/385H01J9/39H01J9/40H10W29/00H01J2217/49264
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,725,751
App. No.
18/498,767
Granted
Sep 1, 2026
Kind
B2
Abstract

Implantable medical devices including a housing that contains operational circuitry for the implantable medical device and a dispensed hydrogen getter. The hydrogen getter may include a getter carrier material and one or more getter materials carried as suspensions in the getter carrier material, with the getter materials taking the form of organic compounds, such as fatty acids, or powdered metal oxides, or combinations thereof. The hydrogen getter may instead be comprised of two fatty acids having different melt temperatures. The hydrogen getter may be dispensed onto an encapsulant layer or other component of the implantable medical device, or may be blended into an encapsulant layer.

Claims (42)

1 . An implantable medical device comprising:

a housing;

operational circuitry disposed within the housing;

an encapsulant layer surrounding at least a portion of the operational circuitry, the encapsulant layer; and

a dispensed getter comprising each of:

a getter carrier material;

a first getter material formed of an organic material; and

a second getter material formed of a metal oxide;

wherein the first and second getter materials are suspended in the getter carrier material.

2 . The implantable medical device of claim 1 , wherein the getter carrier material has a lower melt temperature than the first getter material and the second getter material.

3 . The implantable medical device of claim 1 , wherein the getter carrier material is hydrogenated styrene-ethylene-butadiene-styrene.

4 . The implantable medical device of claim 1 , further comprising a desiccant material inside the housing, the desiccant material adapted to absorb water molecules formed in the dispensed getter when the metal oxide loses oxygen to the organic material.

5 . The implantable medical device of claim 1 , wherein the first getter material is formed of a fatty acid.

6 . The implantable medical device of claim 1 , wherein the getter carrier material makes up 50% to 95% of the dispensed getter by weight, and the first and second getter carrier materials make up 50% to 5% of the dispensed getter layer by weight.

7 . The implantable medical device of claim 1 , wherein the getter carrier material makes up 50% to 95% of the dispensed getter by volume, and the first and second getter carrier materials make up 50% to 5% of the encapsulant layer by volume.

8 . An implantable medical device comprising:

a housing;

operational circuitry disposed within the housing; and

a dispensed getter directly dispensed into the housing, the dispensed getter comprising each of:

a catalyst material;

a first getter material formed of a first organic material; and

a second getter material formed of a second organic material;

wherein the first getter material has a melt temperature that is at least 20° C. lower than the melt temperature of the second getter material.

9 . The implantable medical device of claim 8 , wherein the dispensed getter is comprised, by weight, of about 10% to about 75% of the first getter material, about 25% to about 90% of the second getter material, and about 0.5% to about 30% of the catalyst material.

10 . The implantable medical device of claim 8 , wherein at least one of the first getter material and the second getter material is formed of a fatty acid.

11 . The implantable medical device of claim 8 , wherein the dispensed getter is comprised, by volume, of about 10% to about 75% of the first getter material, about 25% to about 90% of the second getter material, and about 0.5% to about 30% of the catalyst material.

12 . The implantable medical device of claim 8 , wherein the catalyst material is a metal oxide.

13 . The implantable medical device of claim 8 further comprising an encapsulant layer disposed inside the housing and surrounding at least a portion of the operational circuitry, wherein the dispensed getter is disposed in a cavity formed in the encapsulant layer.

14 . An implantable medical device comprising:

a housing;

operational circuitry disposed within the housing; and

an encapsulant layer surrounding at least a portion of the operational circuitry; and

a dispensed hydrogen getter dispensed onto the encapsulant layer, the dispensed hydrogen getter comprising each of:

a getter carrier material having a first melt temperature; and

a getter material having a second melt temperature;

wherein the first melt temperature is at least 10° C. lower than the second melt temperature.

15 . The implantable medical device of claim 14 , wherein the first melt temperature is at least 20 c lower than the first melt temperature.

16 . The implantable medical device of claim 14 , wherein the getter material includes each of a powdered metal getter material, and an organic getter material, wherein the organic getter material has the second melt temperature.

17 . The implantable medical device of claim 16 , wherein the powdered metal getter material is one of platinum oxide or palladium oxide.

18 . The implantable medical device of claim 16 , wherein the organic getter material is a double or triple bond fatty acid.

19 . The implantable medical device of claim 14 , wherein the getter material comprises a first organic getter material having the first melt temperature, and a second organic getter material having a third melt temperature which is higher than the first melt temperature.

20 . The implantable medical device of claim 14 , wherein the getter carrier material is hydrogenated styrene-ethylene-butadiene-styrene.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2024
From: PROVO, KATHERINE; ENGLISH, JAMES MICHAEL; MCGRATH, SHANE; DELANEY, JOSEPH
To: CARDIAC PACEMAKERS, INC.
Reel/Frame 068205/0034 →
Continuity (3)
Provisional Application 63461978 · Apr 26, 2023
Provisional Application 63447750 · Feb 23, 2023
Related Publication 20240290566A1 · Aug 29, 2024
References Cited (51)
US 4014346A · Brownlee et al. · 1977 [cited by applicant]
US 4254775A · Langer · 1981 [cited by applicant]
US 4314562A · Ware · 1982 [cited by applicant]
US 5876424A · O'Phelan et al. · 1999 [cited by applicant]
US 5999398A · Makl et al. · 1999 [cited by applicant]
US 6031710A · Wolf et al. · 2000 [cited by applicant]
US 6428612B1 · McPhilmy et al. · 2002 [cited by applicant]
US 6603654B2 · Rorvick et al. · 2003 [cited by applicant]
US 6881516B2 · Aamodt et al. · 2005 [cited by applicant]
US 7194309B2 · Ostroff et al. · 2007 [cited by applicant]
US 7263401B2 · Scott et al. · 2007 [cited by applicant]
US 7485277B1 · Shepodd et al. · 2009 [cited by applicant]
US 7769457B2 · Fonte · 2010 [cited by applicant]
US 7968226B2 · Aamodt et al. · 2011 [cited by applicant]
US 8065006B2 · Rorvick et al. · 2011 [cited by applicant]
US 8065007B2 · Ries et al. · 2011 [cited by applicant]
US 8463393B2 · Strother et al. · 2013 [cited by applicant]
US 8774921B2 · Fonte · 2014 [cited by applicant]
US 9105899B2 · Pakula et al. · 2015 [cited by applicant]
US 9713725B2 · Bobgan et al. · 2017 [cited by applicant]
US 10040021B2 · Ries et al. · 2018 [cited by applicant]
US 10226055B2 · Rothfuss et al. · 2019 [cited by applicant]
US 10434316B2 · Kelley et al. · 2019 [cited by applicant]
US 10894164B2 · Strommer et al. · 2021 [cited by applicant]
US 11247059B2 · Keller et al. · 2022 [cited by applicant]
US 20030204216A1 · Ries et al. · 2003 [cited by applicant]
US 20050245971A1 · Brockway et al. · 2005 [cited by applicant]
US 20090034769A1 · Darley et al. · 2009 [cited by applicant]
US 20100305654A1 · Fonte · 2010 [cited by applicant]
US 20120069536A1 · Sporon-Fiedler et al. · 2012 [cited by applicant]
US 20130235550A1 · Stevenson et al. · 2013 [cited by applicant]
US 20150196867A1 · Ries et al. · 2015 [cited by applicant]
US 20150321013A1 · Smith et al. · 2015 [cited by applicant]
US 20160151635A1 · Frysz et al. · 2016 [cited by applicant]
US 20160287865A1 · Bobgan et al. · 2016 [cited by applicant]
US 20180207427A1 · Webb et al. · 2018 [cited by applicant]
US 20190168005A1 · Li et al. · 2019 [cited by applicant]
US 20190321628A1 · Stevenson et al. · 2019 [cited by applicant]
US 20200054881A1 · Frustaci et al. · 2020 [cited by applicant]
US 20200121417A1 · Prescott et al. · 2020 [cited by applicant]
US 20200246625A1 · Stevenson et al. · 2020 [cited by applicant]
US 20200276440A1 · Stevenson et al. · 2020 [cited by applicant]
US 20210121705A1 · Ries et al. · 2021 [cited by applicant]
US 20220047876A1 · Becklund et al. · 2022 [cited by applicant]
US 20220249852A1 · Peterson · 2022 [cited by applicant]
US 20220288401A1 · Landherr et al. · 2022 [cited by applicant]
US 20240245923A1 · English · 2024 [cited by examiner]
EP 2934670B1 · 2018 [cited by applicant]
WO 2012036944A1 · 2012 [cited by applicant]
Henkel, Presentation, Macromelt Molding, 35 pages, https://www.ellsworth.com/globalassets/literature-library/manufacturer/henkel-loctite/henkel-presentation-technolmelt-formerly-branded-as-macromelt-molding.pdf Accessed… [cited by applicant]
International Search Report and Written Opinion dated Nov. 19, 2021 for International Application No. PCT/US2021/045724. [cited by applicant]